S A Gregory

2.6k total citations
22 papers, 2.2k citations indexed

About

S A Gregory is a scholar working on Pharmacology, Immunology and Organic Chemistry. According to data from OpenAlex, S A Gregory has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in S A Gregory's work include Inflammatory mediators and NSAID effects (6 papers), Macrophage Migration Inhibitory Factor (3 papers) and Synthesis and biological activity (2 papers). S A Gregory is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Macrophage Migration Inhibitory Factor (3 papers) and Synthesis and biological activity (2 papers). S A Gregory collaborates with scholars based in United States, United Kingdom and Finland. S A Gregory's co-authors include Thomas S. Edgington, Peter C. Isakson, Graham Anderson, Scott D. Hauser, James H. Morrissey, Karen Seibert, Neal Nathanson, John W. Balliet, Abhay Srinivasan and Henry L. Friedman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

S A Gregory

21 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S A Gregory United States 17 587 519 495 336 318 22 2.2k
S. Tam Hong Kong 30 768 1.3× 585 1.1× 132 0.3× 179 0.5× 94 0.3× 98 2.4k
C Kunsch United States 10 665 1.1× 838 1.6× 124 0.3× 73 0.2× 291 0.9× 17 2.0k
H.W.L. Ziegler-Heitbrock Germany 25 726 1.2× 1.8k 3.5× 157 0.3× 154 0.5× 168 0.5× 59 3.1k
P. Jonathan United States 36 1.3k 2.3× 1.1k 2.1× 416 0.8× 85 0.3× 110 0.3× 62 3.6k
Jenn‐Haung Lai Taiwan 31 825 1.4× 887 1.7× 221 0.4× 131 0.4× 88 0.3× 83 2.7k
Ulrich Mahlknecht Germany 30 1.3k 2.2× 458 0.9× 87 0.2× 336 1.0× 370 1.2× 76 2.7k
Andrea Fattorossi Italy 33 1.1k 1.8× 1.0k 2.0× 104 0.2× 183 0.5× 147 0.5× 141 3.5k
Ling‐Jun Ho Taiwan 30 749 1.3× 644 1.2× 284 0.6× 66 0.2× 82 0.3× 68 2.4k
Xuebin Qin United States 33 1.1k 1.9× 1.4k 2.6× 93 0.2× 252 0.8× 244 0.8× 93 3.6k
Soumya Panigrahi United States 21 681 1.2× 387 0.7× 58 0.1× 190 0.6× 210 0.7× 37 1.7k

Countries citing papers authored by S A Gregory

Since Specialization
Citations

This map shows the geographic impact of S A Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Gregory more than expected).

Fields of papers citing papers by S A Gregory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Gregory. The network helps show where S A Gregory may publish in the future.

Co-authorship network of co-authors of S A Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of S A Gregory. A scholar is included among the top collaborators of S A Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Gregory. S A Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Varrato, J.D., Andrew Siderowf, Peter C. Damiano, et al.. (2001). Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology. 57(2). 357–359. 59 indexed citations
5.
Portanova, Joseph P., Graham Anderson, Scott D. Hauser, et al.. (1996). Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.. The Journal of Experimental Medicine. 184(3). 883–891. 359 indexed citations
6.
Anderson, Graham, et al.. (1996). Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.. Journal of Clinical Investigation. 97(11). 2672–2679. 481 indexed citations
7.
Anderson, Graham, Earl G. Burton, J. Nita Cogburn, et al.. (1996). ChemInform Abstract: 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents.. ChemInform. 27(10). 4 indexed citations
8.
Rader, Randall K., et al.. (1996). T cell activation is regulated by voltage-dependent and calcium-activated potassium channels. The Journal of Immunology. 156(4). 1425–1430. 52 indexed citations
9.
Huff, Rita M., Claire Collins, Søren Kramer, et al.. (1995). A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2). Inflammation Research. 44(S2). S145–S146. 23 indexed citations
10.
Reitz, David B., Hechang Huang, Daniel J. Garland, et al.. (1995). ChemInform Abstract: Selective Cyclooxygenase Inhibitors: Novel 4‐Spiro 1,2‐ Diarylcyclopentenes are Potent and Orally Active COX‐2 Inhibitors.. ChemInform. 26(34). 1 indexed citations
11.
Collman, Ronald G., John W. Balliet, S A Gregory, et al.. (1992). An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. Journal of Virology. 66(12). 7517–7521. 320 indexed citations
12.
Colamonici, O R, Lawrence M. Pfeffer, F D'Alessandro, et al.. (1992). Multichain structure of the IFN-alpha receptor on hematopoietic cells. The Journal of Immunology. 148(7). 2126–2132. 68 indexed citations
13.
Warren, William H., et al.. (1990). Chylothorax secondary to obstruction of the superior vena cava: a complication of the LeVeen shunt.. Thorax. 45(12). 978–979. 16 indexed citations
14.
Colamonici, O R, F D'Alessandro, MO Diaz, et al.. (1990). Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor.. Proceedings of the National Academy of Sciences. 87(18). 7230–7234. 47 indexed citations
15.
Gregory, S A, James H. Morrissey, & Thomas S. Edgington. (1989). Regulation of Tissue Factor Gene Expression in the Monocyte Procoagulant Response to Endotoxin†. Molecular and Cellular Biology. 9(6). 2752–2755. 67 indexed citations
16.
Morrissey, James H., S A Gregory, Nigel Mackman, & T S Edgington. (1989). Tissue factor regulation and gene organization.. PubMed. 6. 67–84. 16 indexed citations
17.
Gregory, S A, James H. Morrissey, & Thomas S. Edgington. (1989). Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.. Molecular and Cellular Biology. 9(6). 2752–2755. 260 indexed citations
18.
Kornbluth, Richard S., S A Gregory, & T S Edgington. (1988). Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.. The Journal of Immunology. 141(6). 2006–2015. 17 indexed citations
19.
Blumenthal, Robert, et al.. (1985). Cloning of a restriction-modification system from Proteus vulgaris and its use in analyzing a methylase-sensitive phenotype in Escherichia coli. Journal of Bacteriology. 164(2). 501–509. 121 indexed citations
20.
McClead, Richard E. & S A Gregory. (1984). Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infection and Immunity. 44(2). 474–478. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026